Creative Medical Technology Holdings Inc (CELZ)

[OldVette]

From: https://clinicaltrials.gov/ct2/show/NCT03699943

So the actual completion date was this year????

Intervention Model Description:
Caverstem 1.0 - Low dose - 30 cc - 20 patients

Caverstem 1.0 - High dose - 60 cc - 20 patients

Caverstem 2.0 - 20 cc - 100 patientsMasking:Single (Outcomes Assessor)

Primary Purpose:TreatmentOfficial

Title:Feasibility Study of Intra-cavernosal Administration of Non-Expanded Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.

Actual Study Start Date  :December 8, 2015

Actual Primary Completion Date  :August 31, 2018

Actual Study Completion Date  :August 31, 2019